Lin Qingxuan (02657) announced interim results, net profit of 256 million yuan, an increase of 40.7% over the previous year

According to the Zhitong Finance App, Lin Qingxuan (02657) announced the 2026 interim results, with revenue of 1,499.7 billion yuan, up 42.6% year on year; net profit of 256 million yuan, up 40.7% year on year; basic profit of 1.81 yuan per share.

Revenue increased year-on-year during the period, mainly due to increased revenue from essential oils, lotions, toners, and creams. The increase is mainly due to the introduction of new SKUs driving the increase in product sales and the upgrading of existing core products.

The company has established a comprehensive sales network, strategically combining diversified online channels with a strong offline layout through deep integration of online and offline. This strategy of online and offline integration not only enhances the depth of interaction between brands and consumers, but also drives sustainable omni-channel growth.

Furthermore, Lin Qingxuan attaches great importance to R&D and innovation, which is regarded as the cornerstone of the brand's core competitiveness. The company's R&D service focuses on independent research and development. Combined with strategic cooperation, it focuses on in-depth exploration and application of camellia ingredients and related skincare technology, and continues to iterate product development close to consumer needs. As of June 30, 2026, the company has 151 experienced R&D personnel. The team members cover various fields such as botany, biology, dermatology and applied chemistry. More than 58% of them have master's degrees or higher to ensure the professionalism and forward-looking nature of R&D activities. In terms of R&D investment, R&D costs during the reporting period were RMB 34 million, an increase of 88.8% over the previous year, reflecting the company's long-term commitment to technological innovation.